Renal function in patients with thalassemia major receiving Exjade® dispersible tablets and a new film-coated tablet formulation of deferasirox (Nanojade®)

MLA

Vahid Falahati, et al. “Renal Function in Patients with Thalassemia Major Receiving Exjade® Dispersible Tablets and a New Film-Coated Tablet Formulation of Deferasirox (Nanojade®).” Advanced Biomedical Research, vol. 11, no. 1, Jan. 2022, p. 84. EBSCOhost, https://doi.org/10.4103/abr.abr_89_21.

APA

Vahid Falahati, Ali Ghasemi, Mohammad Reza Safari, Kazem Ghaffari, Parsa Yousefichaijan, & Maryam Zamanian. (2022). Renal function in patients with thalassemia major receiving Exjade® dispersible tablets and a new film-coated tablet formulation of deferasirox (Nanojade®). Advanced Biomedical Research, 11(1), 84. https://doi.org/10.4103/abr.abr_89_21

Chicago

Vahid Falahati, Ali Ghasemi, Mohammad Reza Safari, Kazem Ghaffari, Parsa Yousefichaijan, and Maryam Zamanian. 2022. “Renal Function in Patients with Thalassemia Major Receiving Exjade® Dispersible Tablets and a New Film-Coated Tablet Formulation of Deferasirox (Nanojade®).” Advanced Biomedical Research 11 (1): 84. doi:10.4103/abr.abr_89_21.